Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Marketed as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
The medication is being prescribed for type 2 diabetes, moderate-to-severe obstructive sleep apnea or certain forms of MASH because those uses may need to be processed through your regular Medicare Part D plan
It is essential during and after chemotherapy and for a period of 3 weeks after radiotherapy
That full, heavy, overstuffed feeling
These medications mimic natural gut hormones that signal fullness to the brain, helping patients break cycles of overeating
They monitor your dosing
US$ 25.86
US$ 29.31
US$ 20.99
US$ 23.26
US$ 23.45
US$ 29.13
US$ 26.28
US$ 21.35
US$ 27.89
US$ 25.44
